Log in
PatientPhase 1Recruitment closed

동아에스티 - 에보클립틴 + 다파글리플로진

Trial start date
2022.01.10
Screening period2022.01.03 ~ 2022.01.05(Choose date/time when applying)
Recruitment closed

MediCLEO (CLEO) safely and transparently connects participants with clinical and bioequivalence trials. See ongoing trials at a glance and apply with ease.

스페로 주식회사 · CEO 조미현 · 서울특별시 마포구 양화로 19, 4층(합정동, 합정오피스빌딩)

Business Registration No. 367-86-01018 · Tel 010-2604-0216

© 2026 메디클레오. Participation in a clinical trial should be decided voluntarily after a full explanation.